|1.||Koide, Kazunori: 4 articles (01/2014 - 03/2007)|
|2.||Gao, Yang: 2 articles (01/2014 - 05/2013)|
|3.||Albert, Brian J: 2 articles (08/2009 - 03/2007)|
|4.||Czaicki, Nancy L: 2 articles (08/2009 - 03/2007)|
|5.||Trivedi, Sumita: 1 article (01/2014)|
|6.||Ferris, Robert L: 1 article (01/2014)|
|7.||Grabowski, Paula J: 1 article (08/2009)|
|8.||Osman, Sami: 1 article (08/2009)|
|9.||Destefino, Vincent: 1 article (08/2009)|
|10.||Vogt, Andreas: 1 article (08/2009)|
|1.||Lung Neoplasms (Lung Cancer)
08/01/2009 - "Meayamycin exhibited specificity toward human lung cancer cells compared with nontumorigenic human lung fibroblasts and retained picomolar growth-inhibitory activity against multidrug-resistant cells. "
05/17/2013 - "The resulting proapoptotic cellular environment was further exploited; when meayamycin B was combined with Bcl-x(L) inhibitor ABT-737, the combination treatment triggered apoptosis in nonsmall cell lung cancer A549 and H1299 cells that were otherwise resistant to ABT-737. "
|2.||Breast Neoplasms (Breast Cancer)
08/01/2009 - "Its analogue, meayamycin, is two orders of magnitude more potent as an antiproliferative agent against human breast cancer MCF-7 cells. "
03/07/2007 - "The inhibitions of human breast cancer MCF-7 cell proliferation by synthetic FR901464 and meayamycin were studied, and the GI50 values for these compounds were determined to be 1.1 nM and 10 pM, respectively. "
|5.||Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
|1.||RNA Precursors (Precursor, mRNA)